© Reuters.
NEW YORK (Reuters) – A federal appeals court on Tuesday revived a lawsuit by a whistleblower who accused McKesson (NYSE:) of providing drug pricing tools to doctors to induce them to purchase drugs from the company.
The decision by the 2nd U.S. Circuit Court of Appeals in Manhattan restores claims by Adam Hart, a former McKesson business development executive.
PayPal Holdings, Inc. (NASDAQ:PYPL) Bernstein forty first Annual Strategic Choices Convention Might 28, 2025 9:00 AM ET Firm Individuals Alex...
Most of the world’s main manufacturers and retailers depend on B-Inventory—the world’s largest B2B recommerce platform—to shortly and effectively resell...
This text was written byObserveBaird is a world monetary companies agency offering Personal Wealth Administration, Belief, Asset Administration, Funding Banking,...
This text was written byObserveLooking for Alpha's transcripts workforce is answerable for the event of all of our transcript-related initiatives....
This text was written byObserveMichael James McDonald is a inventory market forecaster, creator and former Senior Vice President of Investments...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
